Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.

MLA

Aouba, Achille, et al. “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease.” Blood, vol. 116, no. 20, Nov. 2010, pp. 4070–76. EBSCOhost, https://doi.org/10.1182/blood-2010-04-279240.

APA

Aouba, A., Georgin-Lavialle, S., Pagnoux, C., Martin Silva, N., Renand, A., Galateau-Salle, F., Le Toquin, S., Bensadoun, H., Larousserie, F., Silvera, S., Provost, N., Candon, S., Seror, R., de Menthon, M., Hermine, O., Guillevin, L., & Bienvenu, B. (2010). Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood, 116(20), 4070–4076. https://doi.org/10.1182/blood-2010-04-279240

Chicago

Aouba, Achille, Sophie Georgin-Lavialle, Christian Pagnoux, Nicolas Martin Silva, Amédée Renand, Françoise Galateau-Salle, Sophie Le Toquin, et al. 2010. “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease.” Blood 116 (20): 4070–76. doi:10.1182/blood-2010-04-279240.